Controlled drugs and managing medicines update

Clinical   kit pic

As hopefully you would have read last Thursday (12th January), together we need to address our non compliance with our controlled drugs processes. This was clearly identified to us by the CQC when they inspected us in 2016.

Despite lots of effort to address the variation in our practice, random audits are continuing to identify a lack of adherence to controlled drugs processes. Clearly, this has legal implications as well as regulatory.

In this context, the Trust view is that compliance with what are legally based processes must be considered mandatory. Any example of individual non compliance, e.g. carrying morphine on your person, will therefore be addressed through the Trust's Medicines Management Policy. 

The Executive Leadership Board (SLB) decided this week to review the practices of other trusts where systems and compliance are successfully embedded, but also where there have been problems we can learn from. This reset means we can go into the next few weeks getting the clearest picture possible of what a safe, relevant, compliant management of medicines will look like for our trust, and we will provide regular updates.

Comments can be posted below as always, or please discuss with your clinical managers who can feedback to those involved in the project management.

Mark Patten, Medical Director

Published 19th January, 2017

Leave a Comment
Name (required)
Email Address (required, never displayed)
Enter a message

(all comments are moderated - your submission will be posted on approval.)